GROUP ONE TRADING, L.P. - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is and the CUSIP is 12648L951. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$177,660
+418.6%
42,300
+642.1%
0.00%
Q4 2022$34,257
-75.0%
5,700
-75.7%
0.00%
Q3 2022$137,000
-89.6%
23,500
-89.4%
0.00%
-100.0%
Q2 2022$1,319,000
+1067.3%
221,000
+813.2%
0.00%
Q1 2022$113,000
+769.2%
24,200
+365.4%
0.00%
Q4 2021$13,000
-81.9%
5,200
-78.8%
0.00%
Q3 2021$72,000
+5.9%
24,500
-10.3%
0.00%
Q2 2021$68,000
-30.6%
27,300
-18.8%
0.00%
Q1 2021$98,000
+9700.0%
33,600
+11100.0%
0.00%
Q4 2020$1,0003000.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2020
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 300$1,0000.00%
SIMPLEX TRADING, LLC 26$00.00%
View complete list of CTI BIOPHARMA CORP shareholders